We serve Chemical Name:1-(Chloromethyl)-2-Ethoxybenzene CAS:60906-78-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:1-(Chloromethyl)-2-Ethoxybenzene
CAS.NO:60906-78-7
Synonyms:2-Aethoxy-1-chlormethyl-benzol;2-ethoxybenzyl chloride;2-chloromethyl-phenetole;11-Chlor-2-aethoxy-toluol;2-Chlormethyl-phenetol
Molecular Formula:C9H11ClO
Molecular Weight:170.63600
HS Code:2909309090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:234.1ºC at 760 mmHg
Density:1.082g/cm3
Index of Refraction:1.512
PSA:9.23000
Exact Mass:170.05000
LogP:2.82410
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2-Aethoxy-1-chlormethyl-benzol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Chlormethyl-phenetol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Chlormethyl-phenetol Use and application,2-Aethoxy-1-chlormethyl-benzol technical grade,usp/ep/jp grade.
Related News: APIs are generally manufactured through a variety of processes that include. 1-(Chloromethyl)-2-Ethoxybenzene manufacturer In recent years, China’s bulk drug companies have gradually completed the upgrade of the product structure of bulk raw materials to specialty raw materials and intermediates. The industry’s leading companies have further developed the research and development layout of high-barrier generic pharmaceutical raw materials with multiple patents that have not yet expired. 1-(Chloromethyl)-2-Ethoxybenzene supplier APIs are generally manufactured through a variety of processes that include. 1-(Chloromethyl)-2-Ethoxybenzene vendor Coupled with the poor global pesticide industry situation this year, the weakening of downstream customer demand has affected the sales of pesticide intermediates. 1-(Chloromethyl)-2-Ethoxybenzene factory Large pharmaceutical companies are investing a disproportionately large amount of annual revenue in research and development (R&D), according to GlobalData��s Company Financials database.
